ARCHIVES

“Triple-Negative” Should Be Split Into Subtypes, Say Researchers

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

DCCP Board Okays Concepts Of New Grants Totaling $1.4 Million Year

February 18, 1983

NCI CTEP Approved Trials For the Month of December

December 27, 2013

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977

Cancer Survivorship: NCI, Komen, OWH Fund Research Grants

December 5, 1997

White House Okays Committee ‘Kill’ Lists; Workshops To Plan Projects In Carcinogenesis

July 22, 1977